Ad is loading...
MVMDF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
NXSCF
Price
$0.09
Change
-$0.01 (-10.00%)
Updated
Nov 15 closing price
Ad is loading...

MVMDF vs NXSCF

Header iconMVMDF vs NXSCF Comparison
Open Charts MVMDF vs NXSCFBanner chart's image
Mountain Valley MD Holdings
Price$0.02
Change-$0.00 (-0.00%)
Volume$11.89K
CapitalizationN/A
NEXT SCIENCE
Price$0.09
Change-$0.01 (-10.00%)
Volume$25K
CapitalizationN/A
MVMDF vs NXSCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVMDF vs. NXSCF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVMDF is a Hold and NXSCF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MVMDF: $0.02 vs. NXSCF: $0.09)
Brand notoriety: MVMDF and NXSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MVMDF: 20% vs. NXSCF: 160%
Market capitalization -- MVMDF: $11.46M vs. NXSCF: $82.26M
MVMDF [@Pharmaceuticals: Other] is valued at $11.46M. NXSCF’s [@Pharmaceuticals: Other] market capitalization is $82.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MVMDF’s FA Score shows that 0 FA rating(s) are green whileNXSCF’s FA Score has 0 green FA rating(s).

  • MVMDF’s FA Score: 0 green, 5 red.
  • NXSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, MVMDF is a better buy in the long-term than NXSCF.

Price Growth

MVMDF (@Pharmaceuticals: Other) experienced а -5.00% price change this week, while NXSCF (@Pharmaceuticals: Other) price change was -5.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
NXSCF($82.3M) has a higher market cap than MVMDF($11.5M). MVMDF YTD gains are higher at: -36.455 vs. NXSCF (-55.000). MVMDF has higher annual earnings (EBITDA): -5.94M vs. NXSCF (-11.94M). MVMDF has more cash in the bank: 10.9M vs. NXSCF (7.37M). MVMDF has less debt than NXSCF: MVMDF (14K) vs NXSCF (276K). NXSCF has higher revenues than MVMDF: NXSCF (10.4M) vs MVMDF (110K).
MVMDFNXSCFMVMDF / NXSCF
Capitalization11.5M82.3M14%
EBITDA-5.94M-11.94M50%
Gain YTD-36.455-55.00066%
P/E RatioN/AN/A-
Revenue110K10.4M1%
Total Cash10.9M7.37M148%
Total Debt14K276K5%
FUNDAMENTALS RATINGS
MVMDF: Fundamental Ratings
MVMDF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEIX10.47-0.08
-0.76%
Lazard Emerging Markets Core Equity Inst
RGGYX24.59-0.24
-0.97%
Victory RS Global Y
RGAFX80.01-1.34
-1.65%
American Funds Growth Fund of Amer R5
GSBGX26.08-0.45
-1.70%
GMO Small Cap Quality Fund Class VI
APDMX38.95-1.06
-2.65%
Artisan Mid Cap Advisor

MVMDF and

Correlation & Price change

A.I.dvisor tells us that MVMDF and NXSCF have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MVMDF and NXSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MVMDF
1D Price
Change %
MVMDF100%
-1.30%
NXSCF - MVMDF
12%
Poorly correlated
-3.18%
MCUJF - MVMDF
11%
Poorly correlated
-16.81%
OASMY - MVMDF
9%
Poorly correlated
N/A
NXEN - MVMDF
7%
Poorly correlated
N/A
OILFF - MVMDF
7%
Poorly correlated
+6.37%
More

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and KMDA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
-3.18%
KMDA - NXSCF
27%
Poorly correlated
-0.85%
CTLT - NXSCF
20%
Poorly correlated
+0.32%
APNHY - NXSCF
20%
Poorly correlated
N/A
MVMDF - NXSCF
12%
Poorly correlated
-1.30%
OMID - NXSCF
6%
Poorly correlated
N/A
More